TickerGuard
Buy Day today: Good (62) Broad market participation · no major macro event
OCUL

Ocular Therapeutix Inc

Healthcare · Biotechnology

10.10$ +2.7% vs. previous close Closing price · As of: Sep 17, 2026

Statements

Balance Sheet

Ocular Therapeutix Inc (OCUL) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 671 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet OCUL
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
162 252 539 517 490 458 406 451 411 808 733 671
141 232 520 499 473 441 388 433 387 782 706 644
111 196 483 460 427 392 350 391 345 737 667 599
111 196 483 460 427 392 350 391 345 737 667 599
24 26 27 30 30 32 25 30 31 31 24 30
2.3 2.3 2.6 2.5 2.4 3.0 3.3 3.0 3.5 3.6 3.7 3.8
155 161 131 139 138 143 140 145 153 154 151 151
35 35 24 30 36 41 38 43 49 51 48 49
1.9 1.6 1.5 1.7 1.7 1.9 2.2 2.6 2.8 2.8 3.2 3.1
4.0 4.4 6.5 3.7 4.0 4.2 4.6 5.9 6.3 4.2 8.0 7.0
74 75 66 67 68 69 69 70 71 71 72 73
7.9 91 408 378 352 315 266 306 258 654 582 520
-668 -698 -762 -806 -843 -891 -955 -1,023 -1,092 -1,157 -1,246 -1,324
85 109 132 166 167 168 169 173 184 223 224 225

Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?